Catalyst OrthoScience said today that it raised nearly $13 million for the total shoulder replacement device it developed. The $12.7 million oversubscribed Series C-1 round was led by River Cities Capital Funds, Naples, Fla.-based Catalyst said. “This funding will be instrumental in fueling rapid growth for Catalyst through increased inventory, expanded distribution and new product development,” […]
Haemonetics deals S.C. plant to CSL Plasma for $10m
Haemonetics (NYSE:HAE) said today that it agreed to sell a plant in South Carolina to CSL Plasma for $10 million. The Union, S.C., facility makes the liquid saline and sodium citrate solutions used in plasma collection. CSL Plasma, the supplier for CSL Behring, will own and operate the plant, taking on “substantially all” of the roughly […]
Balt wins CE Mark for Titan aspiration catheter
Balt said yesterday that it won CE Mark approval in the European Union for the Titan aspiration catheter. The catheter dates back to the September 2016 acquisition of endovascular device developer Blockade Medical and its Barricade coil. Blockade’s facility in Irvine, Calif., became the headquarters for Balt’s new American subsidiary, with Blockade co-founder, president & […]
HealthpointCapital takes majority stake in CrossRoads Extremity Systems
CrossRoads Extremity Systems said today that HealthpointCapital took out a majority stake for an undisclosed amount. The New York City-based private equity firm, which specializes in musculoskeletal plays, aims to fuel rapid growth via market expansion and bolt-on acquisitions, Memphis-based CrossRoads said. The company makes a line of foot and ankle repair devices that use […]
Abiomed wins expanded, 14-day indication for Impella pumps
Abiomed (NSDQ:ABMD) said today that it won an expanded indication from the FDA for two of its Impella heart pumps, extending their indwell times from six to 14 days. The federal safety watchdog’s decision affects the Impella 5.0 and Impella LD devices used to treat cardiogenic shock, Danvers, Mass.-based Abiomed said. The company won the […]
Supremes extend deadline for False Claim Act cases
The U.S. Supreme Court today effectively extended the deadline on whistleblower lawsuits filed under the False Claims Act, even when the feds decline to intervene, in a unanimous decision. Under the FCA, a case must be filed within six years of a violation or three years from the date when the facts are known or […]
Ex-Abiomed exec looks to keep wrongful termination suit alive
A former Asia VP for Abiomed (NSDQ:ABMD) is hoping to keep a wrongful termination lawsuit alive in a U.S. federal appeals court. In January Keisuke Suzuki lost a lawsuit seeking $2.1 million in damages for unfair termination and denial of an options deal tied to Japanese approval of Abiomed’s Impella heart pump. The Danvers, Mass.-based company […]
Histogenics completes transformation into Ocugen with $7m deal for NeoCart
UPDATED May 14, 2019, with comment from Medavate. Histogenics (NSDQ:HSGX) said today that it completed another step on its transformation into clinical-stage biopharmaceutical company Ocugen, with a nearly $7 million deal to sell its NeoCart regenerative knee treatment to Medavate. The $6.5 million all-cash deal, signed May 8, will see all of the NeoCart assets pass […]
Stealthy Route 92 Medical raises $13m
Stealthy catheter developer Route 92 Medical, which is developing a catheter to treat stroke, last week said it raised nearly $13 million in an equity round. Founded in 2015, San Mateo, Calif.-based Route 92 won 510(k) clearance from the FDA a year ago for a percutaneous catheter. The company holds U.S. patents for treating acute […]
HRS 2019 Roundup: Medtronic touts extravascular ICD pilot
The pilot study of an extravascular implantable cardiac defibrillator developed by Medtronic (NYSE:MDT), which is designed to deliver both defibrillation and anti-tachycardia pacing using leads placed outside the heart and venous system, showed strong safety and efficacy results. The safety outcome for the 26-patient study, presented last week at the annual meeting of the Heart […]
ICU Medical’s Q1 numbers beat estimates
ICU Medical (NSDQ:ICUI) beat the consensus estimates for its first-quarter sales and earnings and stood fast on its guidance for the rest of the year, but saw its share price fall anyway on Wall Street today. San Clemente, Calif.-based ICU posted profits of $31.0 million, or $1.44 per share, on sales of $330.9 million for the […]
- 1
- 2
- 3
- …
- 483
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube